Contract 75A50123C00010
Albert B. Sabin Vaccine Institute, Inc. (The) · Department Of Health And Human Services · July 16, 2024
Albert B. Sabin Vaccine Institute, Inc. (The) was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on July 16, 2024 for $57.29 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Washington, DC. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost-plus contract pricing. The most recent modification was on July 29, 2025. If all options are exercised, the contract could reach $238.38 million.
Contract details
- PIID
- 75A50123C00010
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care - Other; Applied Research
- Place of performance
- Washington, DC
- First action
- July 16, 2024
- Latest action
- July 29, 2025
Description
THE PURPOSE OF THIS MODIFICATION IS TO 1. EXERCISE OPTION PERIOD 2 CLIN 0003 WITH A PERIOD OF PERFORMANCE OF JULY 22, 2025, TO DECEMBER 28, 2032, IN THE AMOUNT OF $38,697,183.73. AS A RESULT OF THIS MODIFICATION: 1. FUNDING IN THE AMOUNT OF $3
Modification timeline
-
July 29, 2025Mod P00012 · Exercise An Option$158.81M
-
July 8, 2025Mod P00011 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: 1. CLIN 0008 (OPTION 7) THE TOTAL UNEXERCISED VALUE IS HEREBY DECREASED FROM $8,443,038.00 BY $1,554,748.99 TO $6,888,289.01 TO ACCOUNT FOR A DECREASE I…$120.11M
-
September 25, 2024Mod P00006 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO CHANGE PRODUCTION UNDER CLIN 0005 AND CLIN 0006 AND EXTEND THE PERIOD OF PERFORMANCE ON CLIN 0005 AS FOLLOWS: 1. CLIN 0005 (OPTION 4) IS HEREBY AMENDED AS FOLLOW…$88.42M
-
August 23, 2024Mod P00005 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS NO COST MODIFICATION IS TO INCORPORATE AN UPDATED STATEMENT OF WORK AMENDING THE VERBIAGE AS FOLLOWS: 1. CLIN 0001 IS HEREBY AMENDED PERFORM ACTIVITIES TO FILL-FINISH 2L OF SUDV DR…$71.39M
-
July 16, 2024Mod P00004 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS $0 MODIFICATION IS TO: 1. CLIN 0001 IS HEREBY AMENDED TO INCLUDE AN ADDITIONAL 4TH DS BATCH RUN OF SUDV, AND TO REFLECT THE INCREASE OF REITHERA?S SUBCONTRACT BY $585,000 AT NO ADD…$71.39M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123C00010?
Contract 75A50123C00010 is a federal contract awarded to Albert B. Sabin Vaccine Institute, Inc. (The) by Department Of Health And Human Services on July 16, 2024 for $57.29 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 75A50123C00010?
Albert B. Sabin Vaccine Institute, Inc. (The) won contract 75A50123C00010 from Department Of Health And Human Services.
How much is contract 75A50123C00010 worth?
Contract 75A50123C00010 has obligated $57.29 million to date, with a total potential value of $238.38 million if all options are exercised.